PHANES THERAPEUTICS TO PRESENT AT BIOTECH SHOWCASE™ 2020 IN SAN FRANCISCO

December 12, 2019

Company will showcase its bispecific antibody platform PACbody and immuno-oncology pipeline... Read more

‚Äč

MERCK TO PROVIDE BIORELIANCE   END-TO-END SOLUTIONS TO PHANES THERAPEUTICS

July 24, 2019

Merck, a leading science and technology company, today announced... Read more

PHANES AND FOSUN KITE FORM STRATEGIC ALLIANCE FOR INNOVATIVE CAR-T PRODUCTS TO TREAT SOLID TUMORS

November 7, 2019

Phanes Therapeutics and Phanes Biopharmaceuticals (“Phanes”) recently formed... Read more

CROWNBIO ENTERS STRATEGIC PARTNERSHIP WITH PHANES THERAPEUTICS TO ACCELERATE DISCOVERY AND DEVELOPMENT OF PHANES’ NOVEL ONCOLOGY AGENTS

March 13, 2018

Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International... Read more

PHANES AND HANMI ANNOUNCE LICENSING AGREEMENT TO DEVELOP BI- AND/OR MULTI-SPECIFIC ANTIBODIES

September 17, 2019

Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery... Read more

WUXI BIOLOGICS AND PHANES ANNOUNCE STRATEGIC PARTNERSHIP

December 14, 2017

WuXi Biologics, a leading global open-access biologics technology... Read more

®